John Glasspool

John Glasspool is an accomplished executive in the biotechnology and healthcare sectors, currently serving as the Chief Executive Officer of VarmX since November 2024. Glasspool holds significant positions including a member of the Board Emerging Companies Section Governing Board for the Biotechnology Innovation Organization and a Venture Partner at Agent Capital, focusing on investments in novel therapeutics. Glasspool also serves on the Board of Relmada Therapeutics, Inc., and has worked as a Senior Advisor for the Massachusetts Institute of Technology-NEWDIGS. Previously, Glasspool was the CEO and President of Anthos Therapeutics and held multiple board roles, including DalCor Pharmaceuticals. Expertise includes corporate strategy, business development, and commercial infrastructure in biopharmaceuticals, with a strong educational background in business administration and clinical pharmacology.